Overview

Ticagrelor vs. Clopidogrel in Post PCI Patients

Status:
Completed

Trial end date:
2023-03-01

Target enrollment:

Participant gender:

Summary

Elective PCI were included in the study. Patients were randomized into two different groups. One group took ASA 80 mg once daily and clopidogrel 75 mg once a day, and the other one took ASA 80 mg once a day and ticagrelor 90 mg twice a day. After six months of close follow-up, patients were asked to give a score to their dyspnea and asked about the major advance cardiovascular events ( MACE)

Phase:

N/A

Details

Lead Sponsor:

Shiraz University of Medical Sciences

Treatments:

Clopidogrel
Ticagrelor